Human monoclonal antibody MBL-HCV1 delays HCV viral rebound following liver transplantation: a randomized controlled study.

doi:10.1111/ajt.12083

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Community

Back to search

Article

Human monoclonal antibody MBL-HCV1 delays HCV viral rebound following liver transplantation: a randomized controlled study.

American journal of transplantation : official journal of the American Society of Transplantation and the American Society of Transplant Surgeons - 1 Apr 2013

Chung R T, Gordon F D, Curry M P, Schiano T D, Emre S, Corey K, Markmann J F, Hertl M, Pomposelli J J, Pomfret E A, Florman S, Schilsky M, Broering T J, Finberg R W, Szabo G, Zamore P D, Khettry U, Babcock G J, Ambrosino D M, Leav B, Leney M, Smith H L, Molrine D C

Abstract excerpt

Rapid allograft infection complicates liver transplantation (LT) in patients with hepatitis C virus (HCV). Pegylated interferon-α and ribavirin therapy after LT has significant toxicity and limited efficacy. The effect of a human monoclonal antibody targeting the HCV E2 glycoprotein (MBL-HCV1) on viral clearance was examined in a randomized, double-blind, placebo-controlled pilot study in patients infected with...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Antibodies, Monoclonal

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics

Share to Biopsy

Share to Double-Blind Method

Share to Hepacivirus

Share to Hepatitis C

Share to Liver Transplantation

Share to Pilot Projects

Share to Viral Envelope Proteins

Source

Open in PubMed Open full text

Identifiers

PMID: 23356386
DOI: 10.1111/ajt.12083
PMCID: PMC3618536

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 6 Sept 2026. Manifest publication-graph-cohort-2026-09-06.1.

Source receipt: pubmed, retrieved 6 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 8 closest

Human monoclonal antibody MBL-HCV1 delays HCV viral rebound following liver transplantation: a randomized controlled study.PMID 23356386Read ↗

Human monoclonal antibody HCV1 effectively prevents and treats HCV infection in chimpanzees.Semantic proximity Read ↗

Prevention of hepatitis C virus infection using a broad cross-neutralizing monoclonal antibody (AR4A) and epigallocatechin gallate.Semantic proximity Read ↗

A novel neutralizing human monoclonal antibody broadly abrogates hepatitis C virus infection in vitro and in vivo.Semantic proximity Read ↗

Monoclonal anti-claudin 1 antibodies prevent hepatitis C virus infection of primary human hepatocytes.Semantic proximity Read ↗

Safety and anti-HCV effect of prolonged intravenous silibinin in HCV genotype 1 subjects in the immediate liver transplant period.Semantic proximity Read ↗

Viral entry and escape from antibody-mediated neutralization influence hepatitis C virus reinfection in liver transplantation.Semantic proximity Read ↗

Successful anti-scavenger receptor class B type I (SR-BI) monoclonal antibody therapy in humanized mice after challenge with HCV variants with in vitro resistance to SR-BI-targeting agentsSemantic proximity Read ↗

Isolation and Characterization of Broadly Neutralizing Human Monoclonal Antibodies to the E1 Glycoprotein of Hepatitis C VirusSemantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.